Long-Term Outcomes of Laparoscopic Adjustable Silicone Gastric Banding (LAGB) in Moderately Obese Patients With and Without Co-morbidities
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Overweight and obesity independently increase cardiovascular risk, while even modest weight loss can result in clinically significant improvements in cardiovascular risk and reduce long-term mortality. Lowering the body mass index (BMI) threshold for bariatric surgery to those with moderate obesity might be one way to lower the burden of this disease. The aim of this study was to evaluate the efficacy and safety of laparoscopic adjustable silicone gastric banding (LAGB) in moderately obese subjects with or without obesity-related co-morbidities.
Thirty-four patients with BMI between 30 and 35 kg/m2 (5 males/29 females, mean age 36 ± 10 years, mean preoperative weight 87.9 ± 7.1 kg, mean BMI 32.6 ± 1.6 kg/m2 and mean percentage excess weight 48.7 ± 9 %) who underwent LAGB via pars flaccida between June 1, 2002 and August 31, 2010 were included. Good response was defined as BMI <30 kg/m2 or percentage estimated weight loss (%EWL) >50. Poor response was defined as BMI >30 kg/m2 or %EWL less than 50 after a minimum of 1 year.
Mean weight, BMI and %EWL were recorded at 1, 3, 5 and 7 years and were 77.4 ± 7.6, 69.9 ± 10.8, 70.9 ± 9.3 and 73.3 ± 12.0 kg; 28.8 ± 2.9, 26.4 ± 3.2, 26.5 ± 3.4 and 27.4 ± 5.0 kg/m2; and 36 ± 23, 46.1 ± 33.8, 58.6 ± 31.5 and 45 ± 57, respectively (p < 0.01). Co-morbidities were diagnosed in 17/34 (50 %) patients at baseline and underwent remission or improvement in all cases after 1 year.
LAGB in a safe and effective procedure in patients with a BMI <35 kg/m2.
- Clegg A, Colquitt J, Sidhu M, et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes. 2003;27:1167–77. CrossRef
- Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13. CrossRef
- Logue J, Murray HM, Welsh P, et al. Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart. 2011;97:564–8. CrossRef
- Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia. 2009;52:65–73. CrossRef
- Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32. CrossRef
- Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24. CrossRef
- Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review. Surgery. 2004;135:326–51. CrossRef
- Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37. CrossRef
- Schwartz MW, Woods SC, Seeley RJ, et al. Is the energy homeostasis system inherently biased toward weight gain? Diabetes. 2003;52:232–8. CrossRef
- Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007;17:168–75. CrossRef
- Weiner R, Blanco-Engert R, Weiner S, et al. Outcome after laparoscopic adjustable gastric banding - 8 years’ experience. Obes Surg. 2003;13:427–34. CrossRef
- Dargent J. Surgical treatment of morbid obesity by adjustable gastric band: the case for a conservative strategy in the case of failure—a 9-year series. Obes Surg. 2004;14:986–90. CrossRef
- Hollenbeaks CS, Rogers AM, Barrus B, et al. Surgical volume impacts bariatric surgery mortality: a case for centers of excellence. Surgery. 2008;144:736–43. CrossRef
- Parikh M, Laker S, Weiner M, et al. Objective comparison of complications resulting from laparoscopic bariatric procedures. J Am Coll Surg. 2006;202:252–61. CrossRef
- Cobourn C, Mumford D, Chapman MA, et al. Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg. 2010;20:415–22. CrossRef
- Buse JB et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5. CrossRef
- Iovino P, Angrisani L, Galloro G, et al. Proximal stomach function in obesity with normal or abnormal oesophageal acid exposure. Neurogastroenterol Motil. 2006;18(6):425–32. CrossRef
- Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis. 2007;3:127–33. CrossRef
- O’Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16:1032–40. CrossRef
- Favretti F, Ashton D, Busetto L, et al. The gastric band: first-choice procedure for obesity surgery. World J Surg. 2009;33:2039–48. CrossRef
- Burns EM, Naseem H, Bottle A, et al. Introduction of laparoscopic bariatric surgery in England: observational population cohort study. BMJ. 2010;341:c4296. CrossRef
- Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg. 2003;14:1157–64. CrossRef
- Dixon JB, Straznicky NE, Lambert EA, et al. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol. 2011;8:429–37. CrossRef
- Vertruyen M. Experience with Lap-Band System up to 7 years. Obes Surg. 2002;12:569–72. CrossRef
- Micheletto G, Roviaro G, Lattuada E, et al. Adjustable gastric banding for morbid obesity. Our experience. Ann Ital Chir. 2006;77:397–400.
- Dargent J. Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution. Obes Surg. 1999;9:446–52. CrossRef
- Torchia F, Mancuso V, Civitelli S, et al. LapBand System in super-super obese patients (60 kg/m2): 4-year results. Obes Surg. 2009;19:1211–5. CrossRef
- Watkins BM, Ahroni JH, Michaelson R, et al. Laparoscopic adjustable gastric banding in an ambulatory surgery center. Surg Obes Rel Dis. 2008;4(Suppl):S56–62. CrossRef
- te Riele WW, Boerma D, Wiezer MJ, et al. Long-term results of laparoscopic adjustable gastric banding in patients lost to follow-up. Br J Surg. 2010;97:1535–40. CrossRef
- Sivagnanam P, Rhodes M. The importance of follow-up and distance from centre in weight loss after laparoscopic adjustable gastric banding. Surg Endosc. 2010;24:2432–8. CrossRef
- Angrisani L, Favretti F, Furbetta F, et al. Italian Group for Lap-Band System: results of multicenter study on patients with BMI ≤35 kg/m2. Obes Surg. 2004;14:415–8. CrossRef
- US Food and Drug Administration: FDA expands use of banding system for weight loss [press release on the Internet]. Washington, DC: US Department of Health and Human Services; 2011 Feb 16. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm245617.htm (2011). Accessed 17 Oct 2011
- De Luca M, Busetto L, Angrisani L. Position statement. Chirurgia Bariatrica BMI 30–35 e Comorbidità. http://www.sicob.org/00_materiali/attivita/statement_BMI_30_35.pdf (2013).
- Long-Term Outcomes of Laparoscopic Adjustable Silicone Gastric Banding (LAGB) in Moderately Obese Patients With and Without Co-morbidities
Volume 23, Issue 7 , pp 897-902
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Body mass index (BMI)
- Lap band
- Laparoscopic adjustable silicone gastric banding (LAGB)
- Long term
- Weight loss
- Industry Sectors
- Author Affiliations
- 1. General and Endoscopic Surgery Unit, S.Giovanni Bosco Hospital, ASL NA1 Centro, via S.Lucia 143, 80132, Napoli, Italy
- 2. Department of Clinical and Experimental Medicine, University Federico II, Naples, Italy